49
Growth Score in past quarter
pts
Heat Score 49 in past quarter
-24 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2318463
Single-use disposable dry-powder inhalers.
- Gidi Kahana: CEO
About the Company
Aespira Ltd. is an inhaler product company which is setting a new standard for single-use disposable dry-powder inhalers (DPIs). The company is developing a pipeline of novel inhaler products using generic drugs. Aespira’s inhalers are especially appropriate for delivery of drugs requiring prevention of contamination and cross-contamination, simple
use by non-trained patients, single-dose and/or non-chronic usage, or clear audible dose confirmation. The company has developed the ActiveMesh technology: A novel and proprietary method of packaging dry-powder drugs within a mesh-based package, and is now developing a disposable and hygienic whistle-shaped inhaler device – the resQhaler.